Live Breaking News & Updates on வருவாய் புள்ளிவிவரங்கள்

Stay updated with breaking news from வருவாய் புள்ளிவிவரங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bahamas was near top of tax-to-GDP ratio increase in LAC region pre-COVID, IDB study finds


“The COVID-19 pandemic caused a sharp decline in tax and resource revenues in 2020”
NASSAU, BAHAMAS The Bahamas saw the second largest increase in tax-to-GDP ratios between the two years preceding the onset of the COVID-19 pandemic, according to a recently released Inter-American Development Bank (IDB) analysis.
According to the Revenue Statistics in Latin America and the Caribbean 2021 analysis, the largest increases in tax-to-GDP ratios between 2018 and 2019 occurred in Nicaragua with a rise of 2.7 percentage points (23.2-25.9) and The Bahamas with a rise of two percentage points in total tax revenue as a percentage of GDP, from 16.7 in 2019 to 18.7 in 2019.
According to the IDB, the analysis shows that the average tax-to-GDP ratio in the LAC region rose to 22.9 percent in 2019, an increase of 0.3 percentage points, due largely to increases in the Caribbean sub-region. ....

United States , Antigua And Barbuda , New Providence , American Development Bank , Inter American Development Bank , Revenue Statistics , Latin America , South America , Central America , ஒன்றுபட்டது மாநிலங்களில் , ஆன்டிகுவா மற்றும் பார்புடா , புதியது ப்ராவிடெந்ஸ் , அமெரிக்கன் வளர்ச்சி வங்கி , இடை அமெரிக்கன் வளர்ச்சி வங்கி , வருவாய் புள்ளிவிவரங்கள் , லத்தீன் அமெரிக்கா , தெற்கு அமெரிக்கா , மைய அமெரிக்கா ,

SARS-CoV-2 COVID Vaccine Market Demands, Growth, Size, Supply and Key Players are Pfizer, BioNTech, Moderna, AstraZeneca, Novovax, J&J and Others


Share this article
Share this article
PUNE, India, April 27, 2021 /PRNewswire/ ReportnReports provides a comprehensive overview of the size of the SARS-CoV-2 COVID Vaccine market, segmentation of the industry (by geography and vaccine technology), key players and the vast potential of vaccines that are in clinical trials. Kelly Scientific analysis indicates that the global COVID vaccine market was worth $59 billion in 2021. However, our forecast indicates that an initial drop in 2022 will occur due to a number of factors including single booster shots as opposed to two shot vaccines and reduced prices in vaccines due to competition.
The COVID vaccine industry is expected to then grow significantly at a CAGR of over 9% and reach $47.5 billion by 2026. This is due to an opening up of the market from a closed government dominated space to one in which private healthcare providers and companies can purchase vaccines. There will also be a continued significant un-met need ....

United States , United Kingdom , South Africa , South African , Prnewswire Reportnreports , Astrazenecajj Gamaleya , Ganesh Pardeshi , Sinovac Sinopharm Bharat , Biontech Moderna Curevac , Biotechnology Companies , National Cancer Institute , Company Financials , Trinity College Dublin , World Health Organization , Top Pharmaceutical Companies , Drug Association , Vaccine Market Research , Vaccine Market Research Report Direct Purchase , Royal College Of Surgeons , Free Sample Copy , Market Research Report , Top Key Players Analysis , Research Report , New England Journal , Bharat Biotech , Kelly Scientific ,